Table 1

Overall statistics for EOC patients, patients with benign or low malignant potential (LMP) tumors, and healthy persons and patients with benign diseases as controls (A), clinicopathologic characteristics of FIGO I/II and FIGO III/IV patients (B) and diagnosis of patients with benign diseases (C)
A)
Cohort 1 Typ Number FIGO Age ± SD [years] Range [years]
Controls Healthy 90 n. a. 46.7 ± 16.8 19 - 83
Cystadenoma 6 n. a. 57.3 ± 8.5 45 - 66
LMP 8 n. a. 60.0 ± 18.6 32 - 92
Malignant disease Ovarian cancer 19 FIGO I-II 55.5 ± 16.7 15 - 85
220 FIGO III-IV 58.6 ± 11.8 18 - 83
Cohort 2
Controls Healthy 30 n. a.
Benign gynecological diseases 35 n. a. 47.3 ± 13.2 25 - 74
Malignant disease (overlapping with cohort 1) Ovarian Cancer 14 FIGO I-II
210 FIGO III-IV
B)
FIGO I-II patients 19
  Histology
   Serous 14
   Endometrioid 2
   Mucinous 1
   Undifferentiated 2
  FIGO
   Ia 2
   Ic 7
   IIa 4
   IIb 2
   IIc 4
  Grade (1 missing)
   1 4
   2 6
   3 8
FIGO III-IV patients 220
  Histology (1 missing)
   Serous 194
   Endometrioid 4
   Mucinous 3
   Undifferentiated 6
   Mixed epithelial 12
  FIGO (3 missing)
   IIIa 4
   IIIb 7
   IIIc 166
   IV 40
  Grade (4 missing)
   1 8
   2 51
   3 157
C)
Benign diseases 35
Cystadenoma (mucinous) 9
Endometriosis 5
Ovarian fibroma 2
Uterine myoma 9
Miscellaneous (two with inflammatory conditions) 10

Pils et al.

Pils et al. BMC Cancer 2013 13:178   doi:10.1186/1471-2407-13-178

Open Data